AdAdvertisement

Category

Knee Osteoarthritis

Articles in this category

Hip Fracture Risk in Elderly Adults: Evaluating Prediction Tools

9/25/2024

Hip Fracture Risk in Elderly Adults: Evaluating Prediction Tools

πŸ₯ Discover the latest insights on hip fracture risk prediction in elderly adults. Explore how FRAX, Garvan, and femoral neck BMD alone compare in predicting hip fractures. πŸ©ΊπŸ“ŠA recent study reveals that simple bone mineral density measurements can be as effective as complex tools. Clinicians should prioritise hip BMD, life expectancy, and patient preferences in treatment decisions. Read more about the findings and their implications for clinical practice. #SyenzaNews #HipFractureRisk #HealthcareResearch #MedicalInsights
Read Article β†’
The Economic Impact of Fall Prevention in Hospitals: Evaluating the Fall TIPS Program

9/23/2024

The Economic Impact of Fall Prevention in Hospitals: Evaluating the Fall TIPS Program

🌟 Did you know that hospital falls contribute to a staggering $17 billion in preventable costs annually? Our latest article explores the economic impact of the Fall TIPS Program, an evidence-based strategy proven to reduce falls and save healthcare systems millions. Discover how investing in fall prevention not only enhances patient safety but also supports financial sustainability in healthcare. Read more here! πŸ‘‰ #SyenzaNews #Healthcare #PatientSafety #FallPrevention #CostSavings #ValueBasedHealthcare #HealthInnovation
Read Article β†’
Preventing Falls Among Older Adults: A Vital Healthcare Imperative

9/18/2024

Preventing Falls Among Older Adults: A Vital Healthcare Imperative

πŸ§“πŸ‘΅ Falls among the elderly are a significant concern. Read our latest insight to explore the awareness and preventive measures of fall risks among older adults in Buraidah, Qassim. Discover key findings and strategies to reduce fall incidents. #SyenzaNews #ElderlyCare #FallPrevention #HealthAwareness #PatientSafety Let's work together to raise awareness and implement effective strategies to prevent falls among older adults.
Read Article β†’
Enhancing Osteoarthritis Management Through Health Economics

8/22/2024

Enhancing Osteoarthritis Management Through Health Economics

πŸšΆβ€β™‚οΈ Enhancing Osteoarthritis Management Through Health Economics πŸšΆβ€β™€οΈ 🌟 Discover the importance of cost-effectiveness in osteoarthritis treatments! 🌟 Learn how health economics influences osteoarthritis (OA) management, optimising treatment strategies and resource allocation efficiency. πŸ“Š #SyenzaNews #Osteoarthritis #CostEffectiveness #HealthEconomics #ValueBasedHealthcare
Read Article β†’
The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from TΓΌrkiye

6/14/2024

The Economic Burden of Knee Arthroplasty Revisions: A Cost Analysis from TΓΌrkiye

🌟 Uncover the escalating economic burden of knee arthroplasty revisions and the critical need for cost-effective healthcare solutions. Let's navigate the evolving landscape of orthopaedic care together! πŸ©ΊπŸ’‘ Discover how innovative healthcare solutions can alleviate the financial strains of knee arthroplasty revisions. Stay informed and join the conversation today! #SyenzaNews #HealthcareEconomics #Orthopedics #MedicalResearch #HealthcareManagement #ResearchInsights πŸ“ŠπŸ”¬
Read Article β†’
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Approvals

6/6/2024

The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Approvals

🌟 Exciting news in the world of osteoporosis treatment! 🌟 Discover how Real-World Evidence (RWE) played a crucial role in the approval of abaloparatide (Eladynos) in the EU. This case study highlights the evolving acceptance of RWE in regulatory decisions, ensuring patient safety and fostering innovation. πŸ“ŠπŸ”¬ #Osteoporosis #RealWorldEvidence #Pharma #RegulatoryAffairs #Healthcare
Read Article β†’
The Cost-Effectiveness of GaitSmart Rehabilitation Programme

4/4/2024

The Cost-Effectiveness of GaitSmart Rehabilitation Programme

Discover the cost-effectiveness of the #GaitSmart Rehabilitation Programme. This innovative solution for gait and mobility issues is showing promising results in cost savings. Read our full article for more insights. #HealthcareInnovation #CostEffectiveHealthcare πŸš€πŸ‘©β€βš•οΈπŸ’°
Read Article β†’
Clinical evidence shows that AposHealth (an FDA-cleared medical device) improves pain, stiffness, and function in people with knee osteoarthritis.

4/21/2023

Clinical evidence shows that AposHealth (an FDA-cleared medical device) improves pain, stiffness, and function in people with knee osteoarthritis.

However, it’s uncertain if these improvements are clinically meaningful. The analyses suggest that AposHealth is cost saving by Β£1,958 per person when compared with standard care if knee surgery is delayed for 5 years. Because the evidence for the potential cost savings is limited, further data collection is recommended to understand if cost savings are made once AposHealth is used in the NHS.
Read Article β†’